Overview
SCIENTIFIC SCORE
Possibly Effective
Based on 16 Researches
7.6
USERS' SCORE
Good
Based on 10 Reviews
8.4
Supplement Facts
Serving Size: 1 Veggie Capsule
Amount Per Serving
%DV
Ginkgo Extract (Ginkgo biloba) (leaf)Providing minimum 24% flavonol glycosides (28.8 mg), 6% terpene lactones (7.2 mg)
120 mg
†
Top Medical Research Studies
8
We examined the effectiveness of a special ginkgo extract, known as EGb 761, in managing vertigo. The study involved rigorous methods, including randomized, double-blind, and placebo-controlled trials, ensuring that the results are reliable and valid.
Our review showcased various experimental and clinical studies focusing on how EGb 761 impacts vestibular compensation—the process that helps our brain adjust to balance and spatial orientation challenges. These studies demonstrated a beneficial effect of the extract in enhancing vestibular compensation both in animals and humans.
Thus, we can confidently say that the evidence supports the efficacy of EGb 761 in treating vertiginous syndromes. This makes ginkgo extract a promising option for individuals who suffer from different types of vertigo.
Our review showcased various experimental and clinical studies focusing on how EGb 761 impacts vestibular compensation—the process that helps our brain adjust to balance and spatial orientation challenges. These studies demonstrated a beneficial effect of the extract in enhancing vestibular compensation both in animals and humans.
Thus, we can confidently say that the evidence supports the efficacy of EGb 761 in treating vertiginous syndromes. This makes ginkgo extract a promising option for individuals who suffer from different types of vertigo.
Read More
8
We conducted a study to compare the effectiveness and safety of Ginkgo biloba extract, known as EGb 761, with betahistine in treating patients suffering from vertigo. In this clinical trial, 160 patients, averaging 58 years old, were split into two groups. One group received EGb 761 at a dosage of 240 mg per day, while the other group was given betahistine at 32 mg per day, both over a span of 12 weeks.
Throughout the treatment period, we utilized various measures to assess the patients' symptoms, including an 11-point scale to gauge their level of vertigo. Both treatments showed improvement across all measures, and there were no statistically significant differences between the two groups regarding how well they responded to treatment. Interestingly, we noticed a trend where patients taking EGb 761 reported slightly better improvements.
In terms of tolerability, EGb 761 emerged as the more favorable option. There were 27 adverse events reported among 19 patients taking Ginkgo biloba, compared to 39 adverse incidents in 31 patients taking betahistine. Overall, both treatments were similarly effective, but EGb 761 was better tolerated, making it a promising alternative for patients dealing with vertigo.
Throughout the treatment period, we utilized various measures to assess the patients' symptoms, including an 11-point scale to gauge their level of vertigo. Both treatments showed improvement across all measures, and there were no statistically significant differences between the two groups regarding how well they responded to treatment. Interestingly, we noticed a trend where patients taking EGb 761 reported slightly better improvements.
In terms of tolerability, EGb 761 emerged as the more favorable option. There were 27 adverse events reported among 19 patients taking Ginkgo biloba, compared to 39 adverse incidents in 31 patients taking betahistine. Overall, both treatments were similarly effective, but EGb 761 was better tolerated, making it a promising alternative for patients dealing with vertigo.
Read More
8
We conducted a study to explore the effectiveness of Ginkgo biloba for treating vertigo, a condition often experienced by the elderly. In this double-blinded, randomized clinical trial, we looked at 170 patients aged 60 to 80 who suffered from vertigo related to atherosclerosis. Half of the participants received Ginkgo biloba while the other half were treated with a homeopathic remedy called Vertigoheel.
After six weeks, we examined how both treatments affected the dizziness experienced by the participants. We discovered that both Ginkgo biloba and Vertigoheel led to significant improvements in dizziness scores. The participants reported reductions in dizziness intensity, frequency, and duration, with no noticeable difference in effectiveness between the two treatments.
Our results suggest that Vertigoheel is a viable option for individuals looking for alternatives to Ginkgo biloba in managing atherosclerosis-related vertigo. Importantly, patients tolerated both treatments well, indicating a promising avenue for symptom relief without significant side effects.
After six weeks, we examined how both treatments affected the dizziness experienced by the participants. We discovered that both Ginkgo biloba and Vertigoheel led to significant improvements in dizziness scores. The participants reported reductions in dizziness intensity, frequency, and duration, with no noticeable difference in effectiveness between the two treatments.
Our results suggest that Vertigoheel is a viable option for individuals looking for alternatives to Ginkgo biloba in managing atherosclerosis-related vertigo. Importantly, patients tolerated both treatments well, indicating a promising avenue for symptom relief without significant side effects.
Read More
Most Useful Reviews
9
Effective for aging
15 people found this helpful
Ginkgo from a top producer, Ginkgo biloba is an ancient tree esteemed in traditional Chinese medicine. Known for its antioxidant properties, it may slow aging and normalise tissue or organ function by enhancing circulation. It helps with vertigo, headaches, and memory loss. Ginkgo biloba may also aid in preventing diseases such as Alzheimer's and anxiety. It's a powerful antioxidant, combating damage from free radicals that lead to various illnesses. I regularly purchase it from I`Herb.
Read More
9
Hopeful recovery
1 people found this helpful
Suffering from Meniere’s Syndrome, I found that pharmaceuticals did little for my vertigo and nausea. After trying Ginkgo biloba, my symptoms eased within days, and I’ve regained hope of full recovery. I no longer experience vertigo or vomiting, just lingering fullness and ringing in my ears.
Read More
9
Stopped vertigo attacks
I bought this for my mother to address dizziness, as advised by her doctor. The vertigo has disappeared, and even months after stopping the supplement, she remains symptom-free.
Read More
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 16 Researches
7.6
- All Researches
9
We conducted a robust study to evaluate how effective Ginkgo biloba extract, known as GBE50, is for treating dizziness related to cerebral arteriosclerosis. This involved a well-structured multi-center trial that was double-blind and randomized. We gathered 404 participants across ten hospitals in China, allowing us to compare results thoroughly.
Participants were divided into two groups: one received GBE50 along with a placebo version of Naoxinqing tablets, and the other received a placebo version of GBE50 with the real Naoxinqing tablets. We primarily measured the Traditional Chinese Medicine symptom pattern scores after six weeks of treatment, alongside various secondary outcomes related to dizziness levels.
After the treatment, we found that the GBE50 group had a higher success rate in reducing symptoms compared to the control group. Specifically, the effectiveness rate was about 92.67% for the GBE50 group, while the control group had a rate of 83.07%, indicating a statistically significant difference. Importantly, we found no significant difference in the occurrence of side effects between the two groups, supporting the safety of GBE50.
Overall, our findings suggest that using Ginkgo biloba extract can effectively treat dizziness due to cerebral arteriosclerosis, all while maintaining a good safety profile. However, we recommend further exploration to understand the impact of combining it with other treatments.
Participants were divided into two groups: one received GBE50 along with a placebo version of Naoxinqing tablets, and the other received a placebo version of GBE50 with the real Naoxinqing tablets. We primarily measured the Traditional Chinese Medicine symptom pattern scores after six weeks of treatment, alongside various secondary outcomes related to dizziness levels.
After the treatment, we found that the GBE50 group had a higher success rate in reducing symptoms compared to the control group. Specifically, the effectiveness rate was about 92.67% for the GBE50 group, while the control group had a rate of 83.07%, indicating a statistically significant difference. Importantly, we found no significant difference in the occurrence of side effects between the two groups, supporting the safety of GBE50.
Overall, our findings suggest that using Ginkgo biloba extract can effectively treat dizziness due to cerebral arteriosclerosis, all while maintaining a good safety profile. However, we recommend further exploration to understand the impact of combining it with other treatments.
Read More
9
We conducted a randomized study involving 84 patients to evaluate the effects of Epley's maneuver, both alone and combined with certain medications, including Ginkgo biloba, on benign paroxysmal positional vertigo (BPPV). Participants were divided into two groups: one received only Epley's maneuver, while the other was treated with Epley's maneuver along with Betahistine mesilate, flunarizine hydrochloride, and Ginkgo biloba extract.
After just one week, we found that the group receiving Ginkgo along with Epley’s maneuver had a significantly higher cure rate (78.57% vs. 50.00%) and total effective rate (92.86% vs. 80.95%) compared to the control group. However, after four weeks, the difference in success rates between the two groups was not statistically significant.
Interestingly, when we looked at recurrence rates after six months, fewer patients in the group that used Ginkgo experienced a relapse of symptoms (7.14% vs. 16.67%), indicating that the combination therapy might be more effective in preventing future episodes. Overall, our findings suggest that Epley's maneuver, especially when paired with Ginkgo, is an effective treatment for vertigo that can potentially reduce recovery time and recurrence of symptoms.
After just one week, we found that the group receiving Ginkgo along with Epley’s maneuver had a significantly higher cure rate (78.57% vs. 50.00%) and total effective rate (92.86% vs. 80.95%) compared to the control group. However, after four weeks, the difference in success rates between the two groups was not statistically significant.
Interestingly, when we looked at recurrence rates after six months, fewer patients in the group that used Ginkgo experienced a relapse of symptoms (7.14% vs. 16.67%), indicating that the combination therapy might be more effective in preventing future episodes. Overall, our findings suggest that Epley's maneuver, especially when paired with Ginkgo, is an effective treatment for vertigo that can potentially reduce recovery time and recurrence of symptoms.
Read More
8
We explored how flunarizine, when combined with ginkgo leaf extract and dipyridamole injection, can impact hemorheology and improve symptoms of vertigo in elderly patients. The study involved 105 elderly participants with vertigo, dividing them into two groups: one receiving the combination treatment and the other receiving flunarizine alone.
The findings revealed that combining ginkgo with flunarizine was associated with a significantly higher treatment success rate of 94.4% compared to 75.9% in the control group. We noted better improvements in blood flow velocity in the arteries that supply the brain, as well as enhanced balance and reduced dizziness symptoms, which indicates the treatment's potential effectiveness.
Furthermore, we didn't observe any significant rise in adverse reactions, suggesting that this combined approach is safe for older adults dealing with vertigo. Overall, our study indicates that incorporating ginkgo into treatment regimens could offer meaningful benefits for elderly patients suffering from vertigo.
The findings revealed that combining ginkgo with flunarizine was associated with a significantly higher treatment success rate of 94.4% compared to 75.9% in the control group. We noted better improvements in blood flow velocity in the arteries that supply the brain, as well as enhanced balance and reduced dizziness symptoms, which indicates the treatment's potential effectiveness.
Furthermore, we didn't observe any significant rise in adverse reactions, suggesting that this combined approach is safe for older adults dealing with vertigo. Overall, our study indicates that incorporating ginkgo into treatment regimens could offer meaningful benefits for elderly patients suffering from vertigo.
Read More
8
Ginkgo's impact on childhood vertigo
We explored the effectiveness of using ginkgo biloba in treating recurrent vertigo in children who have unilateral vestibular dysfunction but maintain normal balance. In a structured study, thirty children aged 4 to 13 were divided into groups to receive different treatments. While two groups received specific training—one with vestibulo-ocular reflex adaptation and another with Cawthorne-Cooksey training—the control group didn't undergo any training at all.
All participants were also given drops containing ginkgo biloba. The results indicated that the vestibular rehabilitation training notably improved vertigo symptoms. However, we were unable to isolate the specific effects of ginkgo from the training programs due to the study design.
Thus, while ginkgo was part of the treatment, the overall benefits of the training overshadowed any potential impacts it might have had on its own. It noted that children had a better acceptance of the VOR adaptation program compared to the classic Cawthorne-Cooksey training, pointing towards the potential importance of treatment experience in children.
All participants were also given drops containing ginkgo biloba. The results indicated that the vestibular rehabilitation training notably improved vertigo symptoms. However, we were unable to isolate the specific effects of ginkgo from the training programs due to the study design.
Thus, while ginkgo was part of the treatment, the overall benefits of the training overshadowed any potential impacts it might have had on its own. It noted that children had a better acceptance of the VOR adaptation program compared to the classic Cawthorne-Cooksey training, pointing towards the potential importance of treatment experience in children.
Read More
8
We explored the effectiveness of ginkgo extract, specifically EGb 761, in enhancing recovery from vestibular damage caused by unilateral inner ear impairment in a rat model. The study involved different groups of rats receiving varying doses of ginkgo for six weeks prior to and after a procedure simulating inner ear damage. Control groups were included to establish clear comparisons.
Our findings revealed that the rats receiving the highest dose of ginkgo (75 mg/kg) showed significant improvements in their vestibular function. Particularly, there was a notable reduction in symptoms like nystagmus and postural imbalance soon after the treatment, and these rats demonstrated increased mobility compared to control groups.
Lower doses also led to quicker recovery from postural asymmetry, although they didn't affect mobility as strongly. The study further indicated that ginkgo may influence brain activity, altering glucose metabolism in regions associated with balance and coordination. This suggests that ginkgo could support recovery following acute vestibular loss, encouraging us to consider its potential at higher dosages for vestibular compensation.
Our findings revealed that the rats receiving the highest dose of ginkgo (75 mg/kg) showed significant improvements in their vestibular function. Particularly, there was a notable reduction in symptoms like nystagmus and postural imbalance soon after the treatment, and these rats demonstrated increased mobility compared to control groups.
Lower doses also led to quicker recovery from postural asymmetry, although they didn't affect mobility as strongly. The study further indicated that ginkgo may influence brain activity, altering glucose metabolism in regions associated with balance and coordination. This suggests that ginkgo could support recovery following acute vestibular loss, encouraging us to consider its potential at higher dosages for vestibular compensation.
Read More
User Reviews
USERS' SCORE
Good
Based on 10 Reviews
8.4
- All Reviews
- Positive Reviews
- Negative Reviews
9
Effective for aging
15 people found this helpful
Ginkgo from a top producer, Ginkgo biloba is an ancient tree esteemed in traditional Chinese medicine. Known for its antioxidant properties, it may slow aging and normalise tissue or organ function by enhancing circulation. It helps with vertigo, headaches, and memory loss. Ginkgo biloba may also aid in preventing diseases such as Alzheimer's and anxiety. It's a powerful antioxidant, combating damage from free radicals that lead to various illnesses. I regularly purchase it from I`Herb.
Read More
9
Hopeful recovery
1 people found this helpful
Suffering from Meniere’s Syndrome, I found that pharmaceuticals did little for my vertigo and nausea. After trying Ginkgo biloba, my symptoms eased within days, and I’ve regained hope of full recovery. I no longer experience vertigo or vomiting, just lingering fullness and ringing in my ears.
Read More
9
Stopped vertigo attacks
I bought this for my mother to address dizziness, as advised by her doctor. The vertigo has disappeared, and even months after stopping the supplement, she remains symptom-free.
Read More
9
Balanced living achieved
I purchased Dr Best's extra strength Ginkgo supplements to help with balance and memory issues. The capsules are easy to swallow, and together with other brain health supplements, my vertigo has improved significantly, allowing me to live actively.
Read More
7.5
Reduced vertigo symptoms
7 people found this helpful
My mother suffered from vertigo due to a neck hernia, causing headaches. After 15 days on this supplement, she noticed improvement in both her vertigo and headaches. We tried many ginkgo supplements, but this one, with 120mg of leaf, proved to be very effective.
Read More
Frequently Asked Questions
9
Hopeful recovery
1 people found this helpful
Suffering from Meniere’s Syndrome, I found that pharmaceuticals did little for my vertigo and nausea. After trying Ginkgo biloba, my symptoms eased within days, and I’ve regained hope of full recovery. I no longer experience vertigo or vomiting, just lingering fullness and ringing in my ears.
7.5
Reduced vertigo symptoms
7 people found this helpful
My mother suffered from vertigo due to a neck hernia, causing headaches. After 15 days on this supplement, she noticed improvement in both her vertigo and headaches. We tried many ginkgo supplements, but this one, with 120mg of leaf, proved to be very effective.
9
Stopped vertigo attacks
I bought this for my mother to address dizziness, as advised by her doctor. The vertigo has disappeared, and even months after stopping the supplement, she remains symptom-free.
7.5
Memory and vertigo improvement
I was advised by my doctor to take this supplement for vertigo. This brand has proven trustworthy; after completing the first bottle, my vertigo diminished, and I also experienced improved memory.
9
Balanced living achieved
I purchased Dr Best's extra strength Ginkgo supplements to help with balance and memory issues. The capsules are easy to swallow, and together with other brain health supplements, my vertigo has improved significantly, allowing me to live actively.
9
Effective for Meniere’s
I recommend Ginkgo pills for those with dizziness, vertigo, and tinnitus as an adjunct to Betaserc. Those familiar with Meniere’s disease will understand. The quality is impressive, the ingredients excellent, and the benefits appear quickly.
8
We explored how flunarizine, when combined with ginkgo leaf extract and dipyridamole injection, can impact hemorheology and improve symptoms of vertigo in elderly patients. The study involved 105 elderly participants with vertigo, dividing them into two groups: one receiving the combination treatment and the other receiving flunarizine alone.
The findings revealed that combining ginkgo with flunarizine was associated with a significantly higher treatment success rate of 94.4% compared to 75.9% in the control group. We noted better improvements in blood flow velocity in the arteries that supply the brain, as well as enhanced balance and reduced dizziness symptoms, which indicates the treatment's potential effectiveness.
Furthermore, we didn't observe any significant rise in adverse reactions, suggesting that this combined approach is safe for older adults dealing with vertigo. Overall, our study indicates that incorporating ginkgo into treatment regimens could offer meaningful benefits for elderly patients suffering from vertigo.
The findings revealed that combining ginkgo with flunarizine was associated with a significantly higher treatment success rate of 94.4% compared to 75.9% in the control group. We noted better improvements in blood flow velocity in the arteries that supply the brain, as well as enhanced balance and reduced dizziness symptoms, which indicates the treatment's potential effectiveness.
Furthermore, we didn't observe any significant rise in adverse reactions, suggesting that this combined approach is safe for older adults dealing with vertigo. Overall, our study indicates that incorporating ginkgo into treatment regimens could offer meaningful benefits for elderly patients suffering from vertigo.
9
We conducted a robust study to evaluate how effective Ginkgo biloba extract, known as GBE50, is for treating dizziness related to cerebral arteriosclerosis. This involved a well-structured multi-center trial that was double-blind and randomized. We gathered 404 participants across ten hospitals in China, allowing us to compare results thoroughly.
Participants were divided into two groups: one received GBE50 along with a placebo version of Naoxinqing tablets, and the other received a placebo version of GBE50 with the real Naoxinqing tablets. We primarily measured the Traditional Chinese Medicine symptom pattern scores after six weeks of treatment, alongside various secondary outcomes related to dizziness levels.
After the treatment, we found that the GBE50 group had a higher success rate in reducing symptoms compared to the control group. Specifically, the effectiveness rate was about 92.67% for the GBE50 group, while the control group had a rate of 83.07%, indicating a statistically significant difference. Importantly, we found no significant difference in the occurrence of side effects between the two groups, supporting the safety of GBE50.
Overall, our findings suggest that using Ginkgo biloba extract can effectively treat dizziness due to cerebral arteriosclerosis, all while maintaining a good safety profile. However, we recommend further exploration to understand the impact of combining it with other treatments.
Participants were divided into two groups: one received GBE50 along with a placebo version of Naoxinqing tablets, and the other received a placebo version of GBE50 with the real Naoxinqing tablets. We primarily measured the Traditional Chinese Medicine symptom pattern scores after six weeks of treatment, alongside various secondary outcomes related to dizziness levels.
After the treatment, we found that the GBE50 group had a higher success rate in reducing symptoms compared to the control group. Specifically, the effectiveness rate was about 92.67% for the GBE50 group, while the control group had a rate of 83.07%, indicating a statistically significant difference. Importantly, we found no significant difference in the occurrence of side effects between the two groups, supporting the safety of GBE50.
Overall, our findings suggest that using Ginkgo biloba extract can effectively treat dizziness due to cerebral arteriosclerosis, all while maintaining a good safety profile. However, we recommend further exploration to understand the impact of combining it with other treatments.
8
We explored the effectiveness of ginkgo biloba in treating vertigo, particularly its potential benefits against common conditions that lead to dizziness. The research examined whether ginkgo could offer any real relief to those experiencing vertigo, which can be a frustrating and debilitating condition.
However, the findings suggest that ginkgo may not have significant indications for treating tinnitus, presbycusis (age-related hearing loss), or even anosmia that may result from viral rhinitis. While it is mentioned that ginkgo shows some promise in the context of vertigo, it remains unclear whether it was effective when used alone or if it was part of a combined treatment approach.
Therefore, our assessment indicates that there isn’t concrete evidence supporting ginkgo biloba as a standalone treatment for vertigo. We recognize the need for more focused studies to clarify its role, but currently, the benefits of ginkgo in this area appear limited.
However, the findings suggest that ginkgo may not have significant indications for treating tinnitus, presbycusis (age-related hearing loss), or even anosmia that may result from viral rhinitis. While it is mentioned that ginkgo shows some promise in the context of vertigo, it remains unclear whether it was effective when used alone or if it was part of a combined treatment approach.
Therefore, our assessment indicates that there isn’t concrete evidence supporting ginkgo biloba as a standalone treatment for vertigo. We recognize the need for more focused studies to clarify its role, but currently, the benefits of ginkgo in this area appear limited.
8
We conducted a study to compare the effectiveness and safety of Ginkgo biloba extract, known as EGb 761, with betahistine in treating patients suffering from vertigo. In this clinical trial, 160 patients, averaging 58 years old, were split into two groups. One group received EGb 761 at a dosage of 240 mg per day, while the other group was given betahistine at 32 mg per day, both over a span of 12 weeks.
Throughout the treatment period, we utilized various measures to assess the patients' symptoms, including an 11-point scale to gauge their level of vertigo. Both treatments showed improvement across all measures, and there were no statistically significant differences between the two groups regarding how well they responded to treatment. Interestingly, we noticed a trend where patients taking EGb 761 reported slightly better improvements.
In terms of tolerability, EGb 761 emerged as the more favorable option. There were 27 adverse events reported among 19 patients taking Ginkgo biloba, compared to 39 adverse incidents in 31 patients taking betahistine. Overall, both treatments were similarly effective, but EGb 761 was better tolerated, making it a promising alternative for patients dealing with vertigo.
Throughout the treatment period, we utilized various measures to assess the patients' symptoms, including an 11-point scale to gauge their level of vertigo. Both treatments showed improvement across all measures, and there were no statistically significant differences between the two groups regarding how well they responded to treatment. Interestingly, we noticed a trend where patients taking EGb 761 reported slightly better improvements.
In terms of tolerability, EGb 761 emerged as the more favorable option. There were 27 adverse events reported among 19 patients taking Ginkgo biloba, compared to 39 adverse incidents in 31 patients taking betahistine. Overall, both treatments were similarly effective, but EGb 761 was better tolerated, making it a promising alternative for patients dealing with vertigo.
References
- Liu X, Shu L, Zheng J. Effects of flunarizine combined with ginkgo leaf extract and dipyridamole injection on hemorheology in elderly patients with vertigo. Pak J Med Sci. 2024;40:337. doi:10.12669/pjms.40.3.8456
- Ma N, Liu H, Liu B, Zhang L, Li B, et al. Effectiveness and acceptance of Vestibulo-Ocular Reflex adaptation training in children with recurrent vertigo with unilateral vestibular dysfunction and normal balance function. Front Neurol. 2022;13:996715. doi:10.3389/fneur.2022.996715
- Sha RN, Tang L, Du YW, Wu SX, Shi HW, et al. Effectiveness and safety of Ginkgo biloba extract (GBE50) in the treatment of dizziness caused by cerebral arteriosclerosis: a multi-center, double-blind, randomized controlled trial. J Tradit Chin Med. 2022;42:83.
- Lindner M, Gosewisch A, Eilles E, Branner C, Krämer A, et al. Extract EGb 761 Improves Vestibular Compensation and Modulates Cerebral Vestibular Networks in the Rat. Front Neurol. 2019;10:147. doi:10.3389/fneur.2019.00147
- Yoo MH, Yang CJ, Kim SA, Park MJ, Ahn JH, et al. Efficacy of steroid therapy based on symptomatic and functional improvement in patients with vestibular neuritis: a prospective randomized controlled trial. Eur Arch Otorhinolaryngol. 2017;274:2443. doi:10.1007/s00405-017-4556-1
- Laccourreye O, Werner A, Laccourreye L, Bonfils P. Benefits, pitfalls and risks of phytotherapy in clinical practice in otorhinolaryngology. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134:95. doi:10.1016/j.anorl.2016.11.001
- Xu Y, Fu M, Zhang N. [Efficacy of different treatment on residual symptoms aftercanalith repositioning procedure in patients withbenign paroxysmal positional vertigo]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016;30:1146. doi:10.13201/j.issn.1001-1781.2016.14.015
- Zhang H, Zhang Q, Xu D, Xu M. [Treatment outcome of patients with idiopathic sudden sensorineural hearing loss and concomitant benign paroxysmal positional vertigo]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014;28:1212.
- Sokolova L, Hoerr R, Mishchenko T. Treatment of Vertigo: A Randomized, Double-Blind Trial Comparing Efficacy and Safety of Ginkgo biloba Extract EGb 761 and Betahistine. Int J Otolaryngol. 2014;2014:682439. doi:10.1155/2014/682439
- Agus S, Benecke H, Thum C, Strupp M. Clinical and Demographic Features of Vertigo: Findings from the REVERT Registry. Front Neurol. 2013;4:48. doi:10.3389/fneur.2013.00048
- Zhang H, Geng M, Yan B, Lu X. [Epley's manoeuvre versus Epley's manoeuvre plus labyrinthine sedative in the management of benign paroxysmal positional vertigo: prospective, randomised study]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012;26:750.
- Hamann KF. [Special ginkgo extract in cases of vertigo: a systematic review of randomised, double-blind, placebo controlled clinical examinations]. HNO. 2007;55:258.
- Issing W, Klein P, Weiser M. The homeopathic preparation Vertigoheel versus Ginkgo biloba in the treatment of vertigo in an elderly population: a double-blinded, randomized, controlled clinical trial. J Altern Complement Med. 2005;11:155.
- Orendorz-Fraczkowska K, Pośpiech L, Gawron W. [Results of combined treatment for vestibular receptor impairment with physical therapy and Ginkgo biloba extract (Egb 761)]. Otolaryngol Pol. 2002;56:83.
- Clostre F. [Ginkgo biloba extract (EGb 761). State of knowledge in the dawn of the year 2000]. Ann Pharm Fr. 1999;57 Suppl 1:1S8.
- Cesarani A, Meloni F, Alpini D, Barozzi S, Verderio L, et al. Ginkgo biloba (EGb 761) in the treatment of equilibrium disorders. Adv Ther. 1998;15:291.
